Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Oral formulations of kappa opioid receptor agonists

Oral formulations of kappa opioid receptor agonists

US Patent 11033629 · Granted Jun 15, 2021

Estimated economic value: $11,081,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Oligosaccharide formulations of kappa opioid receptor agonists2024
Oligosaccharide formulations of kappa opioid receptor agonists2024
Diketopiperazine salts for drug delivery and related methods2024
Oral formulations of kappa opioid receptor agonists2023
Oral formulations of kappa opioid receptor agonists2023
Microcrystalline diketopiperazine compositions and methods2021
Diketopiperazine salts for drug delivery and related methods2021
Microcrystalline diketopiperazine compositions and methods2020
Diketopiperazine salts for drug delivery and related methods2020
Microcrystalline diketopiperazine compositions and methods2019
Method for improving the pharmaceutic properties of microparticles comprising di2019
Method for improving the pharmaceutic properties of microparticles comprising di2018